Indusfood Manufacturing 2026 & FoodTech 4.0 Opens at Yashobhoomi (See 'Corp Brief') CCI approves acquisition of Krosaki Harima Corporation by Nippon Steel (See 'Corp Brief') A&C - Right to object to appointment of ineligible arbitrator cannot be taken away by mere implication: SC (See 'Legal Desk') CCI okays acquisition of additional shareholding in Roppen Transportation by MIH Investments (See 'Corp Brief') Ministry of I&B's WaveX signs MoU with FITT-IIT Delhi to boost Innovation (See 'Corp Brief') A&C - Conferment of jurisdiction on specific court or creation of public forum, though eminently significant, may not be decisive test to answer and decide whether arbitrability is impliedly barred: SC (See 'Legal Desk') Working Group discusses Regional Language AI Infrastructure and Reimagining AI Education (See 'Corp Brief') Pax Comfort and Safety enhanced with better Stations: Railways (See 'Corp Brief') IPR - Gaay Chhap had shown prior and continuous use of its marks and made out strong prima facie case of trademark infringement and passing off: HC (See 'Legal Desk') IBBI Chairperson launches IICA PGIP program Website (See 'Corp Brief') Yadav reviews Action Plans of Rajasthan and Punjab to tackle Air Pollution (See 'Corp Brief') IPR - Even if trademark is accepted and advertised and, thereafter, no objection was filed against same, Sec 19 of Trade marks Act empowers Registrar to withdraw acceptance given to said Mark before its registration: HC (See 'Legal Desk') SAIL records Highest-Ever December Sales (See 'Corp Brief') Rajiv Ranjan Singh inaugurates Smart Green Aquaculture Farm (See 'Corp Brief') PMLA - It is not the case of the respondent that the petitioner at any point of time was an accused in the investigation or he was evading arrest - Essential requisites of s.73 of CrPC not met - Non-bailable warrants issued stand cancelled: HC (See 'Legal Desk') Railways utilises 80 Percent of CAPEX in First Three Quarters (See 'Corp Brief') Ships built by GSL & other yards are floating symbols of India's sovereignty: RM (See 'Corp Brief') Misc - A litigant cannot be placed in a situation where a statutory right of appeal is rendered illusory on account of procedural or administrative impediments: HC (See 'Legal Desk') Govt announces relaxation for Deep-Tech Startups for DSIR recognition (See 'Corp Brief') ICAR directed to set up laboratory for turmeric testing in Erode (See 'Corp Brief') SEBI - Levy of penalty shall commensurate to disproportionate gain or unfair advantage or loss caused to investor: SEBI (See 'Legal Desk') Fixed-Term Employment fixed under New Labour Codes (See CORP EINSICHT) Competition Law - When opposite party is not dominant in relevant market, question of abuse of dominant position u/s 4 of Competition Act does not arise: CCI (See 'Legal Desk') NTPC Western Region-I signs MoA with Gujarat Cancer & Research Institute (See 'Corp Brief') PMLA - COVID-19 limitation extension was intended to cover all proceedings, including those under PMLA: SAFEMA (See 'Legal Desk') Coal Output surges as Captive and Commercial Mines Perform Strongly (See 'Corp Brief') IBC - Non- stamping or insufficient stamping of one of documents relied upon by creditor does not impede initiation of insolvency resolution process, which differs from enforcement action: NCLT (See 'Legal Desk') National Textiles Ministers' Conference to be held in Guwahati (See 'Corp Brief') IBC - Penalty can be levied if lapses demonstrated non-compliance with statutory and regulatory obligations incumbent on IP, undermining interests of stakeholders and integrity of insolvency process: IBBI (See 'Legal Desk')

Print

CCI okays internal acquisition by Glaxo Smith Kline

Published: Jan 24, 2022

By TIOLCorplaws News Service

NEW DELHI, JAN 24, 2022: THE Competition Commission of India (CCI) approves acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited (Acquirers) of shareholding in GlaxoSmithKline Asia Private Limited (Target) under Section 31(1) of the Competition Act, 2002.

The Proposed Combination involves collective acquisition of 100% shares of the Target by the Acquirers. Further, prior to the proposed combination, GSKAPL will acquire the trademarks pertaining to "Iodex" and "Ostocalcium" brands in India alongwith the legal, economic, commercial and marketing rights of such brands and other associated assets (GSK Consumer Brands) from GlaxoSmithKline Pharmaceuticals Limited.

GlaxoSmithKline Consumer Healthcare Overseas Limited is a wholly-owned subsidiary of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited ("GSK CH HoldCo"). It is a part of the overall GlaxoSmithkline (GSK) group and its principal activity is to act as an investment holding company for GSK CH HoldCo and its subsidiaries.

GlaxoSmithKline Consumer Healthcare UK Trading Limited is a part of the overall GSK group and is a wholly-owned subsidiary of GSK CH HoldCo. It is engaged in the distribution and sale of consumer healthcare products, manufacturing, marketing, providing management services to the consumer healthcare group and providing research and development services to other consumer healthcare companies within the GSK group.

GSKAPL is a consumer healthcare company that is engaged in the marketing and distribution of oral healthcare products under various brand names such as Sensodyne, Parodontax, Polident and over-the-counter medicines products under the brand names such as Crocin, ENO. 

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.